Medicare Improvements for Patients and Providers Act of 2008/Title III

TITLE III — MISCELLANEOUS

Sec. 301. Extension of TANF Supplemental Grants.

(a) Extension Through Fiscal Year 2009.—

Section 7101(a) of the Deficit Reduction Act of 2005 (Public Law 109-171; 120 Stat. 135) is amended by striking ``fiscal year 2008´´ and inserting ``fiscal year 2009´´.

(b) Conforming Amendment.—

Section 403(a)(3)(H)(ii) of the Social Security Act (42 U.S.C. 603(a)(3)(H)(ii)) is amended to read as follows:

``(ii) subparagraph (G) shall be applied as if ‘fiscal year 2009’ were substituted for ‘fiscal year 2001’; and´´.

Sec. 302. 70 Percent Federal Matching for Foster Care and Adoption Assistance for the District of Columbia.

(a) In General.—

Section 474(a) of the Social Security Act (42 U.S.C. 674(a)) is amended in each of paragraphs (1) and (2) by striking ``(as defined in section 1905(b) of this Act)´´ and inserting ``(which shall be as defined in section 1905(b), in the case of a State other than the District of Columbia, or 70 percent, in the case of the District of Columbia)´´.

(b) Effective Date.—

The amendment made by subsection (a) shall take effect on October 1, 2008, and shall apply to calendar quarters beginning on or after that date.

Sec. 303. Extension of Special Diabetes Grant Programs.

(a) Special Diabetes Programs for Type I Diabetes.—

Section 330B(b)(2)(C) of the Public Health Service Act (42 U.S.C. 254c–2(b)(2)) is amended by striking ``2009´´ and inserting ``2011´´.

(b) Special Diabetes Programs for Indians.—

Section 330C(c)(2)(C) of the Public Health Service Act (42 U.S.C. 254c–3(c)(2)(C)) is amended by striking ``2009´´ and inserting ``2011´´.

(c) Report on Grant Programs.—

Section 4923(b) of the Balanced Budget Act of 1997 (42 U.S.C. 1254c–2 note), as amended by section 931(c) of the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000, as enacted into law by section 1(a)(6) of Public Law 106-554, and section 1(c) of Public Law 107-360, is amended—

(1) in paragraph (1), by striking ``and´´ at the end;

(2) in paragraph (2)—

(A) by striking ``a final report´´ and inserting ``a second interim report´´; and

(B) by striking the period at the end and inserting ``; and´´; and

(3) by adding at the end the following new paragraph:

``(3) a report on such evaluation not later than January 1, 2011.´´.

Sec. 304. IOM Reports on Best Practices for Conducting Systematic Reviews of Clinical Effectiveness Research and for Developing Clinical Protocols.

(a) Systematic Reviews of Clinical Effectiveness Research.—

(1) Study.—

Not later than 60 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall enter into a contract with the Institute of Medicine of the National Academies (in this section referred to as the ``Institute´´) under which the Institute shall conduct a study to identify the methodological standards for conducting systematic reviews of clinical effectiveness research on health and health care in order to ensure that organizations conducting such reviews have information on methods that are objective, scientifically valid, and consistent.

(2) Report.—

Not later than 18 months after the effective date of the contract under paragraph (1), the Institute, as part of such contract, shall submit to the Secretary of Health and Human Services and the appropriate committees of jurisdiction of Congress a report containing the results of the study conducted under paragraph (1), together with recommendations for such legislation and administrative action as the Institute determines appropriate.

(3) Participation.—

The contract under paragraph (1) shall require that stakeholders with expertise in conducting clinical effectiveness research participate on the panel responsible for conducting the study under paragraph (1) and preparing the report under paragraph (2).

(b) Clinical Protocols.—

(1) Study.—

Not later than 60 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall enter into a contract with the Institute of Medicine of the National Academies (in this section referred to as the ``Institute´´) under which the Institute shall conduct a study on the best methods used in developing clinical practice guidelines in order to ensure that organizations developing such guidelines have information on approaches that are objective, scientifically valid, and consistent.

(2) Report.—

Not later than 18 months after the effective date of the contract under paragraph (1), the Institute, as part of such contract, shall submit to the Secretary of Health and Human Services and the appropriate committees of jurisdiction of Congress a report containing the results of the study conducted under paragraph (1), together with recommendations for such legislation and administrative action as the Institute determines appropriate.

(3) Participation.—

The contract under paragraph (1) shall require that stakeholders with expertise in making clinical recommendations participate on the panel responsible for conducting the study under paragraph (1) and preparing the report under paragraph (2).

(c) Funding.—

Out of any funds in the Treasury not otherwise appropriated, there are appropriated for the period of fiscal years 2009 and 2010, $3,000,000 to carry out this section.